GB0905120D0 - Buprenorphine-containing non-pressurised spray composition for transmucisal administration - Google Patents

Buprenorphine-containing non-pressurised spray composition for transmucisal administration

Info

Publication number
GB0905120D0
GB0905120D0 GBGB0905120.2A GB0905120A GB0905120D0 GB 0905120 D0 GB0905120 D0 GB 0905120D0 GB 0905120 A GB0905120 A GB 0905120A GB 0905120 D0 GB0905120 D0 GB 0905120D0
Authority
GB
United Kingdom
Prior art keywords
transmucisal
buprenorphine
administration
containing non
spray composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0905120.2A
Other versions
GB2456434A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmasol Ltd
Original Assignee
Pharmasol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmasol Ltd filed Critical Pharmasol Ltd
Publication of GB0905120D0 publication Critical patent/GB0905120D0/en
Publication of GB2456434A publication Critical patent/GB2456434A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0905120A 2006-10-18 2009-03-25 Buprenorphine-containing non-pressurised spray composition for transmucosal administration Withdrawn GB2456434A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0620661.9A GB0620661D0 (en) 2006-10-18 2006-10-18 Novel compounds
PCT/GB2007/050639 WO2008047163A1 (en) 2006-10-18 2007-10-17 Buprenorphine-containing non-pressurised spray composition for transmucosal administration

Publications (2)

Publication Number Publication Date
GB0905120D0 true GB0905120D0 (en) 2009-05-06
GB2456434A GB2456434A (en) 2009-07-22

Family

ID=37507923

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0620661.9A Ceased GB0620661D0 (en) 2006-10-18 2006-10-18 Novel compounds
GB0905120A Withdrawn GB2456434A (en) 2006-10-18 2009-03-25 Buprenorphine-containing non-pressurised spray composition for transmucosal administration

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0620661.9A Ceased GB0620661D0 (en) 2006-10-18 2006-10-18 Novel compounds

Country Status (8)

Country Link
EP (1) EP2081574A1 (en)
CN (1) CN101573116A (en)
AU (1) AU2007311621A1 (en)
CA (1) CA2666581A1 (en)
GB (2) GB0620661D0 (en)
IL (1) IL197908A0 (en)
WO (1) WO2008047163A1 (en)
ZA (1) ZA200902123B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
SI2054031T1 (en) 2006-07-21 2016-09-30 Biodelivery Sciences International, Inc. Transmucosal delivery devices with enhanced uptake
GB2461681A (en) * 2008-04-17 2010-01-13 Pharmasol Ltd Buprenorphine liquid spray formulation with solvent and antioxidant
EP2152315B1 (en) 2007-05-25 2016-01-06 Indivior UK Limited Sustained delivery formulations of risperidone compounds
WO2010072398A2 (en) * 2008-12-22 2010-07-01 Boehringer Ingelheim Limited Veterinary formulations
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB2513060B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
GB2481728B (en) * 2010-06-30 2012-05-23 Londonpharma Ltd Formulations and delivery devices for the sublingual administration of opioids
MX362217B (en) * 2011-12-21 2019-01-09 Biodelivery Sciences Int Inc Transmucosal drug delivery devices for use in chronic pain relief.
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
CN108463214A (en) * 2015-10-27 2018-08-28 因塞斯发展股份有限公司 liquid buprenorphine formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001274307A1 (en) * 2000-06-22 2002-01-02 Pharmasol Ltd Pharmaceutical compositions
CA2446904A1 (en) * 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
AU2003297087B2 (en) * 2003-02-04 2009-06-11 Philip Morris Products S.A. Aerosol formulations and aerosol delivery of buspirone, buprenorphine, triazolam, cyclobenzaprine and zolpidem
US7500479B2 (en) * 2004-04-23 2009-03-10 Philip Morris Usa Inc. Aerosol generators and methods for producing aerosols

Also Published As

Publication number Publication date
CN101573116A (en) 2009-11-04
EP2081574A1 (en) 2009-07-29
CA2666581A1 (en) 2008-04-24
IL197908A0 (en) 2009-12-24
ZA200902123B (en) 2010-04-28
GB2456434A (en) 2009-07-22
GB0620661D0 (en) 2006-11-29
AU2007311621A1 (en) 2008-04-24
WO2008047163A1 (en) 2008-04-24

Similar Documents

Publication Publication Date Title
GB0905120D0 (en) Buprenorphine-containing non-pressurised spray composition for transmucisal administration
IL195246A0 (en) Atomiser
EP2001498A4 (en) Pharmaceutical compositions
IL194176A0 (en) Pharmaceutical compositions
GB0713625D0 (en) Pharmaceutical compositions
SI2124556T1 (en) Pharmaceutical compositions
ZA200806929B (en) Nebulizer formulation
GB0716905D0 (en) Nozzle
EP2124959A4 (en) Pharmaceutical composition
EP2109454A4 (en) Glp-1 pharmaceutical compositions
EP1983874A4 (en) Nozzle
GB0609434D0 (en) Spray nozzle
GB2443162B (en) Betamethasone spray
GB0617808D0 (en) Nozzle
GB2443161B (en) Clobetasol spray
GB0607667D0 (en) Spray nozzle
GB0515212D0 (en) Compositions for intranasal administration
IL194844A0 (en) New synergistic pharmaceutical composition
GB0612696D0 (en) Pharmaceutical composition
GB0617578D0 (en) Pharmaceutical composition
GB0600032D0 (en) Pharmaceutical composition
GB0605740D0 (en) Spray
ZA200904725B (en) GLP-1 Pharmaceutical compositions
GB0622066D0 (en) Nozzle
ZA200808030B (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)